# A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina

> **NCT02087007** · PHASE3 · COMPLETED · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Vasospastic Angina

## Interventions

- **DRUG:** Cilostazol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02087007
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02087007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02087007, "A Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Cilostazol in Subjects With Vasospastic Angina". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02087007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*